Watermark
Watermark

About Us

We’re building the world’s leading oncology company – driven by scientific excellence and exceptional speed – to reach more patients than ever before.

Together, we are how the world stops cancer.

Happy grandfather embracing grandson outdoors

Our Global Vision

6

Continents with BeOne locations

45+

Countries and regions with clinical trials planned or enrolled

180+

Clinical trials initiated across the globe

45+

Global office locations with exponential headcount growth in the U.S. and EU

Our People

~12,000

Employees working across the globe

1,200+

Research Team

Our Science

30,000+

Patients enrolled in our clinical trials*

80+

Countries with regulatory approval across three internally developed medicines

Watermark
John V. Oyler, Co-Founder, Chairman & Chief Executive Officer of BeOne Leadership.

We have an organization full of wonderful, talented and passionate people; and I think one of the things that you will realize and recognize is, we really believe that we can change the world and believe we’re doing something that’s special.”

John V. Oyler

Co-Founder, Chairman and CEO

Discover More

One Save Changes Everything — And We’re Built To Be Ready

Progress in cancer care is shaped by action at critical moments across research, treatment, and support. Learn how BeOne Medicines’ readiness and innovation from research to delivery is moving cancer care forward.

Delivering Transformative Therapies At Speed

Time is precious when someone is living with cancer. BeOne
Medicines is focused on cancer drug development for cancers
with the highest unmet need through our accelerated pipeline.